arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

NextCure, Inc.

NXTC

$5.15 ▼ -0.72 (-12.27%) at close

9 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

NextCure, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $14.6M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -130.3% ↘

FCF / Share $-17.45 ↗

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$22.38M

↑ +252.6% —

Net Income Profit after all expenses

$-55.84M

— -0.3% —

FCF / Share Free cash flow per share

$-17.45

↑ +5.4% —

Long-Term Debt Long-term obligations

$0.00

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality →

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2017

FY 2018

$0.00

FY 2019

$0.00

FY 2020

$0.00

FY 2021

$0.00

FY 2022

$0.00

FY 2023

$0.00

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	252.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3057%)	—	—	—
EPS Growth YoY (%)	21.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	11.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	16.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	-7.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-0.3% Weak ↓ Weak Declining Year-over-year change in net income	11.3% Fair ↑ Fair Improving Year-over-year change in net income	16.1% Good ↑ Good Improving Year-over-year change in net income	-7.7% Weak ↑ Weak Improving Year-over-year change in net income	-89.6% Weak ↓ Weak Declining Year-over-year change in net income	-8.5% Weak Weak Year-over-year change in net income	-48.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	5.4% Fair ↓ Fair Declining Year-over-year change in free cash flow	23.6% Good ↑ Good Improving Year-over-year change in free cash flow	4.3% Caution Caution Year-over-year change in free cash flow	6.5% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-184.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1328%)	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	-163.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1463%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-232.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	-0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-130.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-72.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	39.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-114.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-52.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-159.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1165%)	-85.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-667%)	-54.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-465%)	-44.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-397%)	-29.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-298%)	-12.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-10.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	48.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+224%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-102%)	—
Interest Coverage (x)	-929.29x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-829.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-835.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-843.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-436.82x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-225.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-179.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	-927.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-25.98M	$-27.73M	$-13.08M	$-26.63M	$-12.34M	$-29.30M	$-29.09M	$-134.71M	—
Debt / EBITDA (x)	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Basic EPS, GAAP (USD)	$-19.65	$-24.88	$-28.12	$-33.62	$-31.37	—	—	—	—
Free Cash Flow per Share (USD)	$-17.45	$-18.45	$-24.16	$-25.23	$-26.98	—	—	—	—
Dividend per Share (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—
Book Value per Share (USD)	$9.97	$29.22	$51.26	$75.40	$105.39	$133.18	$146.13	$-426.82	—
Tangible Book Value per Share (USD)	$9.97	$29.22	$51.26	$75.40	$105.39	$133.18	$146.13	$-426.82	—
Basic Weighted Avg Shares (shares)	2.84M	2.24M	2.23M	2.22M	2.21M	—	—	—	—
Dividend Payout Ratio (%)	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent → Excellent Stable Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$33.18M	$62.23M	$105.84M	$154.86M	$221.21M	$277.65M	$324.95M	$125.49M	—
LT Debt (USD)	—	—	—	$0.00	$0.00	$3.47M	$5.00M	$460.00K	—
Total Equity (USD)	$34.94M	$65.47M	$114.42M	$167.53M	$233.39M	$293.72M	$321.48M	$-46.94M	$-24.41M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$22.38M	$6.35M	—	—
Depreciation Expense (USD)	$2.20M	$2.90M	$3.70M	$4.10M	$4.30M	$3.41M	$2.69M	$1.68M	—
Net Income, GAAP (USD)	$-55.84M	$-55.65M	$-62.72M	$-74.73M	$-69.39M	$-36.60M	$-33.74M	$-22.80M	—
Operating Cash Flow (USD)	$-49.61M	$-40.80M	$-52.97M	$-53.89M	$-57.24M	$-44.95M	$-35.62M	$7.99M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 35 quarters

NextCure, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NXTC with peers